DexCom reported earnings of $ 0.73 per DXCM share on Oct 29, 2026, beating analysts' expectations by
| Report Date | Oct 29, 2026 |
|---|---|
| Forecasted EPS | $ 0.675 |
| Earnings Per Share (Surprise) | $ 0.73 (+$ 0.055) |
| Last Year's EPS | $ 0.5225 |
| EPS YoY Change |
Out of the last 86 earnings reporting periods, DexCom beat analysts’ expectations 38 times and fell short of expectations 29 time(s). DexCom reported earnings per share of $ 0.73 in the last report surpassing an estimated EPS of $ 0.675 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Oct 29, 2026 | $ 0.675 | $ 0.73 | $ 0.61 | |
| Jul 30, 2026 | $ 0.611 | $ 0.70 | $ 0.48 | |
| Apr 30, 2026 | $ 0.4656 | $ 0.56 | $ 0.32 | |
| Feb 12, 2026 | $ 0.65 | $ 0.68 | $ 0.45 | |
| Oct 30, 2025 | $ 0.576 | $ 0.61 | $ 0.45 | |
| Jul 30, 2025 | $ 0.4436 | $ 0.48 | $ 0.43 | |
| May 1, 2025 | $ 0.3272 | $ 0.32 | $ 0.32 | |
| Feb 13, 2025 | $ 0.4792 | $ 0.45 | $ 0.50 | |
| Oct 24, 2024 | $ 0.44 | $ 0.45 | $ 0.50 | |
| Jul 25, 2024 | $ 0.39 | $ 0.43 | $ 0.34 | |
| Apr 25, 2024 | $ 0.27 | $ 0.32 | $ 0.17 | |
| Feb 8, 2024 | $ 0.43 | $ 0.50 | $ 0.34 | |
| Oct 26, 2023 | $ 0.34 | $ 0.50 | $ 0.28 | |
| Jul 27, 2023 | $ 0.23 | $ 0.34 | $ 0.17 | |
| Apr 27, 2023 | $ 0.15 | $ 0.17 | $ 0.08 | |
| Feb 9, 2023 | $ 0.26 | $ 0.34 | $ 0.17 | |
| Oct 27, 2022 | $ 0.24 | $ 0.28 | $ 0.22 | |
| Jul 28, 2022 | $ 0.17 | $ 0.17 | $ 0.19 | |
| Apr 28, 2022 | $ 0.13 | $ 0.08 | $ 0.08 | |
| Feb 10, 2022 | $ 0.22 | $ 0.17 | $ 0.23 |
DexCom’s stock was trading at $ 78.62 on Oct 28, 2026 a day before the last earnings report was released.Following the release of the earnings report, DXCM’s price increased to $ 82.29 on Oct 30, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Oct 29, 2026 | $ 0.73 | $ 78.62 | $ 82.29 | |
| Jul 30, 2026 | $ 0.70 | $ 75.14 | $ 83.45 | |
| Apr 30, 2026 | $ 0.56 | $ 57.56 | $ 61.35 | |
| Feb 12, 2026 | $ 0.68 | $ 68.15 | $ 70.02 | |
| Oct 30, 2025 | $ 0.61 | $ 68.18 | $ 58.22 | |
| Jul 30, 2025 | $ 0.48 | $ 89.35 | $ 80.77 | |
| May 1, 2025 | $ 0.32 | $ 71.38 | $ 81.62 | |
| Feb 13, 2025 | $ 0.45 | $ 83.87 | $ 89.07 | |
| Oct 24, 2024 | $ 0.45 | $ 72.48 | $ 73.44 | |
| Jul 25, 2024 | $ 0.43 | $ 111.94 | $ 64.00 | |
| Apr 25, 2024 | $ 0.32 | $ 137.87 | $ 124.34 | |
| Feb 8, 2024 | $ 0.50 | $ 126.61 | $ 120.47 | |
| Oct 26, 2023 | $ 0.50 | $ 84.35 | $ 89.29 | |
| Jul 27, 2023 | $ 0.34 | $ 130.69 | $ 132.38 | |
| Apr 27, 2023 | $ 0.17 | $ 124.93 | $ 121.34 | |
| Feb 9, 2023 | $ 0.34 | $ 109.84 | $ 117.89 | |
| Oct 27, 2022 | $ 0.28 | $ 102.61 | $ 120.87 | |
| Jul 28, 2022 | $ 0.17 | $ 85.80 | $ 82.08 | |
| Apr 28, 2022 | $ 0.08 | $ 103.25 | $ 102.14 | |
| Feb 10, 2022 | $ 0.17 | $ 111.97 | $ 105.14 |
DexCom released its most recent earnings reports in October 2026, July 2026, April 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
DexCom beat analysts’ expectations during the last earnings period by
